The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples